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Structural and functional properties of NH2-terminal domain, core
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Purpose: The purpose of the present study was to determine the biophysical and chaperone properties of the NH2-terminal
domain, core domain and COOH-terminal extension of human αA- and αB-crystallins and correlate these properties to
those of wild type (WT) αA- and αB-crystallins.
Methods:  WT αA- and αB-crystallins cloned into pET 100D TOPO vector, were used as  templates  to  generate
different constructs encoding specific regions (NH2-terminal domain [NTD], core domain [CD], and COOH-terminal
extension, [CTE]). The specific regions amplified by PCR using plasmid DNA from WT αA and WT αB were: αA NTD
(residues 1–63), αA CD (residues 64–142), αA CTE (residues 143–173), αB NTD (residues 1–66), αB CD (residues 67–
146)  anG α%&T(residues 47–175). Resultant%lunt-end  PCRSroductsZereOigatedWoD SET100'irectional7OPO
vector. DNA sequencing results confirmed the desired constructs. Positive clones were transformed into the BL21 Star
(DE3) expression cell line. Protein expression and solubility were confirmed by SDS–PAGE and western blot analysis
using  a  monoclonal  antibody  against  a  6×  His-tag  epitope.  Proteins  were  purified  using  Ni2+-affinity  column
chromatography, under native or denaturing conditions, and used for biophysical and chaperone function analyses.
Results: A total of five constructs were successfully generated: αA NTD, αA CD, αB NTD, αB CD, and αB CTE. SDS–
PAGE and western blot analyses showed that αA CD and αB CD were present in both the soluble and insoluble fractions,
whereas mutant preparations with NTD alone became insoluble and the mutant with CTE alone became soluble. All
purified constructs showed alterations in biophysical properties and chaperone function compared to WT α-crystallins.
αA NTD and αB CTE exhibited the most notable changes in secondary structural content. Also, αA NTD and all αB-
crystallin constructs showed altered surface hydrophobicity compared to their respective WT α-crystallins.
Conclusions: Although the individual α-crystallin regions (i.e., NH2-terminal domain, core domain, and COOH-terminal
extension) exhibited varied biophysical properties, each region alone retained some level of chaperone function. The
NH2-terminal domains of αA and αB each showed the maximum chaperone activity of the three regions with respect to
their WT crystallins.
Crystallin  proteins  are  the  major  components  of  the
mammalian  lens  fiber  cell  and  are  subdivided  into  three
classes,  α,  β,  and  γ.  The  crystallins  help  to  increase  the
refractive power of the lens and maintain lens transparency by
forming  high  concentrations  of  soluble  oligomers  and
participating in short-range interactions among themselves
[1,2]. Of the crystallins, α-crystallin accounts for almost half
of the total lens protein and its two homologous subunits, αA-
and αB-crystallin, oligomerize to form hetero-oligomers of
~800 kDa in a 3:1 ratio in vivo [2-4]. α-Crystallin is also a
member of the small heat shock protein (sHSP) family, which
are stress-induced proteins of 12–40 kDa subunits containing
a  conserved  α-crystallin  domain  of  ~90  amino  acids  and
flanked on either side by a variable hydrophobic NH2-terminal
domain and a short, hydrophilic unstructured COOH-terminal
extension with a conserved sequence motif [3-8].
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Like other sHSPs, α-crystallins posses chaperone-like
function [9], whereby they recognize and bind destabilized
and improperly folded proteins [7,8]. However, α-crystallins
are ATP-independent chaperones, and cannot refold proteins
[6],  but  sequester  aberrant  proteins  to  prevent  subsequent
formation of light-scattering aggregates. Because there is no
protein  turnover  in  mature  fiber  cells  of  the  lens  [10],
crystallins  must  survive  the  lifetime  of  the  lens  and
transparency  must  be  maintained  despite  environmental
insults and post-translational modifications (PTMs) that occur
with age. In this manner, α-crystallins play a critical role in
the maintenance of lens transparency.
It has been well established that chaperone activity of α-
crystallins is dependent upon oligomerization of α-crystallins
and  substrates  through  hydrophobic  contacts  between
accessible hydrophobic surfaces of α-crystallin and exposed
hydrophobic surfaces of unfolding proteins [9,11]. However,
the  mechanism  of  chaperone  binding  is  still  not  fully
understood and studies have been undertaken to determine
which  sites  of  α-crystallin  are  involved  in  its  chaperone
function.  Many  have  attributed  chaperone  binding  to
hydrophobic sequences in the α-crystallin domain, as well as
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2356in  the  NH2-terminal  domain  (reviewed  in  [3,6,7]).
Specifically, studies suggest a functional chaperone substrate-
binding site resides in residues 70–88 of αA-crystallin [12],
as well as residues 73–92 of αB-crystallin [13]. It has also been
suggested  that  residues  54–61  of  αB-crystallin  play  an
essential role in αB chaperone activity, though unessential for
target protein binding [14]. However, others have identified
several substrate-binding sites in αB-crystallin, including two
NH2-terminal  domain  sequences,  four  α-crystallin  domain
sequences,  and  one  COOH-terminal  extension  sequence,
using protein pin arrays [15].
Mutagenesis,  in  general,  has  been  used  as  a  tool  to
identify  regions  of  α-crystallin  necessary  for  chaperone
function. Studies have generated “point mutations” as well as
“truncation” mutations mimicking naturally occurring PTMs
to study their affects on crystallin structure and function [16,
17]. It has been shown that hereditary point mutations in αA-
crystallin  (R116C)  and  αB-crystallin  (R120G)  cause
structural and functional alterations that lead to congenital
cataract and desmin-related myopathy, respectively [18,19].
Using  site-directed  mutagenesis,  we  mimicked  commonly
occurring age-related deamidations in αA- and αB-crystallin
and demonstrated that N123D deamidation in αA-crystallin
and  N146D  deamidation  in  αB-crystallin  are  crucial  for
chaperone  activity  [20,21].  We  also  performed  a
comprehensive study comparing two PTMs, deamidation and
truncation,  and  showed  that  N123  deamidation  in  αA-
crystallin  [22]  and  N146  deamidation  in  αB-crystallin
(Unpublished), as well as truncation of NH2- and COOH-
termini,  were  detrimental  to  chaperone  function.  Whether
mutations  in  the  NH2-terminal  domain,  α-crystallin  core
domain,  or  the  COOH-terminal  extension  of  α-crystallin
[23-27]  affect  both  structure  and  function  of  the  protein
remains unclear. Previous studies have reported that removal/
swapping of residues/regions from either the NH2-terminal
domain or the COOH-terminal extension in both αA- and αB-
crystallins cause improper folding and reduced chaperone
activity [28-31], however none of these studies have explored
the  structural/functional  stability  of  the  three  individual
regions (i.e., NH2-terminal domain, core domain and COOH-
terminal extension) of αA- and αB-crystallins.
With all the variations in results in the literature, it is still
unclear whether synergistic effects of the three regions or their
specific peptides are responsible for the chaperone activity of
αA- and αB-crystallins. In an attempt to better understand this
phenomenon of which of the three regions is most important
for chaperone activity of αA- and αB-crystallins, we examined
each region (NH2-terminal domain, core domain, and COOH-
terminal extension) individually. The following constructs:
αA  NH2-terminal  domain  (αA  NTD,  residues  1–63),  core
domain  (αA  CD,  residues  64–142)  and  αB  NH2-terminal
domain  (αB  NTD,  residues  1–66),  core  domain  (αB  CD,
residues 67–146), and COOH-terminal extension (αB CTE,
residues 147–175) were generated and used to determine the
structure and function of the individual regions and narrow
down which region is most pertinent to chaperone function.
Our results reveal that despite structural alterations in proteins
representing  the  NH2-terminal  domain,  core  domain,  and
COOH-terminal extension, compared to wild-type (WT) αA-
and  αB-crystallins,  each  protein  individually  displayed  a
reduced  level  of  activity,  with  the  NH2-terminal  regions
showing  maximum  activity  with  respect  to  their  WT
crystallins.
METHODS
Materials:  Molecular  weight  protein  markers  and  DNA
markers were purchased from Invitrogen (Carlsbad, CA) and
Promega (Madison, WI), respectively. Primers used in the
study were obtained from Sigma-Aldrich (St. Louis, MO).
Anti-Histidine-tagged mouse monoclonal primary antibody
and  goat  anti-mouse  IgG  (H+L)  horseradish  peroxidase-
conjugated  secondary  antibody  were  obtained  from
Calbiochem-EMD Biosciences (La Jolla, CA) and Thermo
Scientific (Rockford, IL), respectively. Molecular biology-
grade chemicals were purchased from either Sigma or Fisher
Scientific (Fair Lawn, NJ), unless otherwise stated.
Bacterial strains and plasmids: The Escherichia coli One
Shot® TOP 10 cells and BL21 Star (DE3) bacterial strain were
obtained  from  Invitrogen.  TOP  10  cells  were  used  for
propagation  and  BL21  cells  were  used  for  expression.
Plasmids  containing  WT  αA-  and  αB-crystallin  genes
were already present in the laboratory.
Generation of αA- and αB-crystallin constructs: A plasmid
containing the human WT αA-crystallin gene in pET 100D
TOPO vector (Invitrogen) [20] was used as a template for
generating the desired constructs of αA-crystallin. The WT
αB-crystallin gene [21] was subcloned into pET 100D TOPO
vector (Invitrogen) and was used as a template for generating
the desired constructs of αB-crystallin. Cloning in the pET
100  Directional  TOPO  vector  added  a  six  His-tag  at  the
NH2-terminus  of  the  protein,  which  allowed  us  to  purify
cloned proteins in a single affinity chromatographic step using
a  Ni2+-  affinity  column.  PCR-based  deletion  was  used  to
generate the desired constructs, using specific complimentary
primer  pairs  (Table  1).  The  following  constructs  were
generated  by  PCR-directed  mutagenesis:  (i)  NH2-terminal
domain consisting of residues no. 1–63 of αA and residues no.
1–66 of αB, (ii) Core domain consisting of residues no. 64–
142 of αA and residues no. 67–146 of αB, and (iii) COOH-
terminal extension consisting of residues no. 143–173 of αA
and residues no. 147–175 of αB. Briefly, 25 ng of template
was  used  under  the  following  PCR  conditions:  pre-
denaturation at 95 °C for 5 min, followed by 30 cycles of
denaturation at 95 °C for 1 min, annealing at 62–68 °C for 45
s  (depending  on  the  Tm  of  the  primers),  and  extension/
elongation at 72 °C for 1 min, with a final extension at 72 °C
for 10 min. PCR products were ligated into the pET 100
Directional  TOPO  vector  as  per  the  manufacturer’s
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2357instructions. Deletions at desired sites were confirmed by
DNA sequencing (Genomics Core Facility of the University
of  Alabama  at  Birmingham,  Birmingham,  AL)  at  the
transcriptional level, and by western blot analysis using an
anti-His tag monoclonal antibody at the translational level.
Positive clones were transformed into E. coli BL21 Star (DE3)
cells, and selected using ampicillin.
Expression and extraction of soluble proteins and proteins in
inclusion bodies: PCR amplicons were transformed into E.
coli BL21 Star (DE3) cells, as previously described, using a
standard E. coli transformation technique [20]. Isopropyl-β-
D-thio-galactoside (IPTG), at a final concentration of 1 mM,
was added to overexpress the proteins, and cell cultures were
incubated for 4 h at 37 °C. Cells were harvested, resuspended
in lysis buffer (25 mM Tris-HCl [pH 7.8], 50 mM NaCl, 0.9%
glucose, 1 mM EDTA, containing lysozyme [0.25 mg/ml] and
protease inhibitor cocktail [Sigma]) and sonicated while kept
on  ice.  DNA  was  degraded  by  treatment  with  DNase  I
(10  μg/ml)  for  30  min  on  ice.  The  soluble  fraction  was
separated by centrifugation at 8,000× g for 10 min at 4 °C, and
the insoluble fraction was resuspended in detergent buffer
(DB; 0.5 M NaCl, 1% [w/v] sodium deoxycholate, 1% NP-40,
and 20 mM Tris-HCl, pH 7.5). Further, the detergent-soluble
fraction was separated by centrifugation at 5,000× g for 10
min at 4 °C. The resultant pellet was washed with 0.5% Triton
X-100 and centrifuged, as stated above, and the washing step
was repeated as necessary to remove bacterial debris from the
inclusion  bodies.  The  final  pellet  was  resuspended  in
denaturating binding buffer (DBB; [8M urea, 0.5 M NaCl, and
20 mM sodium phosphate, pH 7.8]).
Purification  of  WT  αA-  and  WT-αB-crystallins  and  their
constructs: Depending on the presence of expressed proteins
in soluble fractions or inclusion bodies (insoluble fractions),
each  protein  was  purified  under  native  or  denaturing
conditions. All purification steps were performed at 4 °C,
unless otherwise stated, including refolding steps. Proteins
samples  were  adsorbed  on  an  Invitrogen  ProBond  Ni2+-
chelating  column  according  to  the  manufacturer’s
instructions.  Under  native  conditions,  the  column  was
equilibrated and loaded with the protein sample using a native
binding (NB) buffer (20 mM sodium phosphate containing 0.5
M NaCl, pH 7.8), washed with NB buffer containing 20 mM
imidazole (pH 7.8), and eluted with NB buffer containing
250 mM imidazole (pH 7.8). Under denaturing conditions, the
column  was  equilibrated  with  DBB,  and  following  the
application  of  desired  protein  preparation,  the  unbound
proteins were eluted by a first wash with DBB; followed by a
second and third wash with DBB at pH 6.0 and pH 5.3,
respectively. Finally, the bound proteins were eluted with
DBB containing 250 mM imidazole (pH 7.8).
Fractions  recovered  from  Ni2+-affinity  column
chromatography under native or denaturing conditions were
analyzed by SDS–PAGE [32]. Those purified under native
conditions were dialyzed against 50 mM phosphate buffer (pH
7.8) at 4 °C, and stored at −20 °C until needed. Proteins
purified under denaturing conditions were refolded using a
previously published method [33] as briefly described below.
Purity of WT αA- and αB-crystallins and their constructs was
examined by SDS–PAGE and their identities were confirmed
by  western  blot  analyses  [34]  using  an  anti-His-tagged
monoclonal  antibody.  Protein  concentrations  were
determined by absorbance at 280 nm using a NanoDrop 2000
spectrophotometer (Thermo Scientific).
Refolding of proteins purified under denaturing conditions:
Proteins purified under denaturing conditions were refolded
by 24 h dialysis at 4 °C against 50 mM sodium phosphate (pH
7.5)  containing  1  mM  DTT  and  decreasing  urea
concentrations from 8 M to 4 M, and finally in a urea-free
phosphate buffer [33].
Characterization of structural/functional properties of WT
αA- and WT αB-crystallins and their constructs: The studies
described  below  were  performed  with  freshly  purified
preparations of αA- and αB-crystallins. Freezing and thawing
TABLE 1. OLIGONUCLEOTIDE PRIMERS USED FOR GENERATION OF INDIVIDUAL DOMAIN CONSTRUCTS OF αA- AND αB-CRYSTALLINS USING PCR-
BASED DELETION.   
Mutant constructs Direction Primers (5′-3′)
αA NTD Fwd CACCATGGACGTGACCATCCAGCACCCC
  Rev TTACTCAGAGATGCCGGAGTCCAGCACGGT
αA CD Fwd CACCGTTCGATCCGACCGGGACAAGTTCGTC
  Rev TTAACAGAAGGTCAGCATGCCATCGGCAGA
αA CTE Fwd CACCGGCCCCAAGATCCAGACTGGCCTGGAT
  Rev TTAGGACGAGGGAGCCGAGGTGGGGTTCTC
αB NTD Fwd CACCATGGACATCGCCATCCACCACCCC
  Rev TTATGAGAGTCCAGTGTCAAACCAGCT
αB CD Fwd CACCGAGATGCGCCTGGAAAAGGACAGG
  Rev TTAATTCACAGTGAGGACCCCATCAGA
αB CTE Fwd CACCGGACCAAGGAAAGAGGTCTCTGGC
  Rev CTATTTCTTGGGGGCTGCGGTGAC
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2358of  these  preparations,  which  sometimes  caused  their
precipitation, was avoided.
Circular  dichroism  (CD)  spectroscopy:  The  far-UV  CD
spectra of purified WT αA- and WT αB-crystallins and their
constructs were recorded at room temperature over a range of
190 – 260 nm on a Jasco J815 CD spectrometer (Jasco, Easton,
MD) using 0.2 mg/ml of protein in 50 mM sodium phosphate
buffer (pH 7.8), as described previously [22]. A quartz cell of
0.5 mm path length was used, and the reported spectra are an
average of five scans baseline-corrected for the buffer blank
and  smoothed.  The  secondary  structural  contents  of  WT
proteins and constructs were determined by analysis of the CD
spectra using the SELCON3 analysis program.
ANS binding and fluorescence spectroscopy: Binding of a
hydrophobic  probe,  8-anilino-1-naphthalene  sulfonate
(ANS), to WT αA- and WT αB-crystallins and their constructs
was measured by recording fluorescence emission spectra at
400  –  600  nm  with  excitation  at  390  nm,  as  previously
described [20,21]. For this, 15 μl of 0.8 mM ANS (dissolved
in methanol) was added to 0.2 mg/ml of a protein in 50 mM
sodium phosphate buffer (pH 7.8), mixed thoroughly, and
incubated for 15 min at 37 °C before spectroscopy.
Oligomer size determination by dynamic light scattering: A
multiangle  laser  light  scattering  instrument  (Wyatt
Technology, Santa Barbara, CA) coupled to an HPLC system
was used to determine the absolute molar mass of the WT
proteins and their constructs. Prior to their analysis, protein
samples in 50 mM sodium phosphate (pH 7.8) were filtered
through a 0.22 μm filter. Results were acquired using 18
different angles, which were normalized with the 90° detector.
Chaperone activity assay: To assess the ability of different
α-crystallin  constructs  to  prevent  DTT-induced  insulin
aggregation, chaperone activity was determined by following
a previously described method [21]. Aggregation of insulin
by reduction with 20 mM DTT at room temperature, either in
absence or at a 1:1 ratio of different αA- and αB-crystallin
species in 1 ml reaction volumes containing 50 mM sodium
phosphate  (pH  7.8)  was  determined.  Aggregation  was
monitored  by  measuring  light  scattering  at  360  nm  as  a
function  of  time  using  a  Shimadzu  UV-VIS  scanning
spectrophotometer  (model  UV2101  PC;  Shimadzu,
Columbia, MD) equipped with a six-cell positioner and a
temperature controller (Shimadzu model CPS-260).
RESULTS
Confirmation  of  site-specific  deletions  in  αA-  and  αB-
crystallin constructs:   Recombinant WT αA and WT αB
plasmids, present in our laboratory  [20,21], were  used  as 
templates  to  generate  constructs  of individual α-crystallin
domains  (see  Methods).  The  individual  NH2-terminal
domain,  core  domain,  and COOH-terminal extension con-
structs of both αA- and αB-crystallins were generated using
PCR-based deletion and are referred to as αA NTD, αA CD,  
   αA  CTE,  αB  NTD,  αB  CD,  and  αB  CTE  in  the text
(Figure   1).   DNA   sequencing   confirmed   the   desired
constructs:  αA NTD  (residues no. 1–63),  αA CD  (residues
no. 64–142),  αB NTD (residues no. 1–66), αB CD (residues
no. 67–146), and αB CTE (residues no. 147–175).
Expression  and  purification  of  WT  α-crystallins  and
constructs:  Expression  of  WT  αA,  WT  αB,  and  their
constructs was induced in the BL21 Star (DE3) expression cell
line using 1 mM IPTG for 4 h, as previously described [20],
and proteins were recovered in either the soluble fraction,
insoluble fraction (inclusion bodies), or both fractions (Table
2). WT αA, WT αB, and αB CTE proteins were recovered in
the soluble fraction, whereas αA NTD and αB NTD proteins
were recovered in the insoluble fraction. These results were
expected  considering  the  hydrophobic  nature  of  the  NH2-
terminal  domain  and  hydrophilic  nature  of  the  COOH-
terminal extension. However, the αA CD and αB CD proteins
were recovered in both the soluble and insoluble fractions,
suggesting their partial solubility property. The expression
and  solubility  of  individual  proteins  were  confirmed  by
western blot analysis using a specific monoclonal antibody
against a 6× His-tag epitope (data not shown).
Each protein was overexpressed in E. coli at 37 °C and
purified to almost homogeneity, under native or denaturing
conditions, using Ni2+-affinity columns (see Methods). On
SDS–PAGE analysis, the molecular weights (Mr) of purified
His-tagged  WT  αA,  WT  αB,  and  their  constructs  ranged
between 7 and 27 kDa (Figure 2). WT αA and WT αB showed
a Mr of ~25–27 kDa (Figure 2, lanes 2 and 5), while the Mr of
the NH2-terminal domain constructs (αA residues 1–63 and
αB residues 1–66) were ~11–13 kDa, core domain constructs
(αA residues 64–142 and αB residues 67–146) were ~13–
14  kDa,  and  the  COOH-terminal  extension  construct  (αB
residues 147–175) was ~7 kDa (Figure 2, lanes 3, 4, 6–8). The
SDS–PAGE gel showed the highly purified nature of these
proteins, and western blot analysis using a monoclonal anti-
His  antibody  confirmed  their  identity  as  His-tagged  α-
crystallin proteins (data not shown). A 50 kDa band seen in
lane 5 of Figure 2 was a dimer of WT αB as it and the monomer
Figure  1.  Schematic  diagram  showing  the  regions  and  residue
numbers forming the NH2-terminal domain (NTD), core domain
(CD),  and  COOH-terminal  extension  (CTE)  of  αA-  and  αB-
crystallins in the current study. The residues spanned by each domain
were as follows: αA NTD (residues no.1–63), αA CD (residues no.
64–142), αA CTE (residues no. 143–173), αB NTD (residues no. 1–
66), αB CD (residues no. 67–146), and αB CTE (residues no. 147–
175).
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2359of  the  crystallin  showed  immunoreactivity  with  anti-His
tagged monoclonal antibody.
Comparative properties of individual α-crystallin domains
and WT α-crystallins:
Circular dichroism spectral studies—To evaluate the
effect  of  deletion/truncation  of  specific  regions  on  the
secondary structure of both αA and αB, far-UV CD spectra
and secondary structural content of their individual regions
were  determined  (Figure  3  and  Table  3).  As  evident,  the
constructs  exhibited  varied  CD  spectra  (Figure  3A,B)
compared  to  WT  αA-  and  WT  αB-crystallins.  Based  on
secondary  structural  content,  as  determined  using  the
SELCON3 analysis software, WT αA exhibited 21.6% α-
helix, 46.6% β-sheet, 13.4% β-turn, and 17.6% random coil.
Figure 2. SDS–PAGE analysis of purified WT αA, WT αB and their
individual  domain  constructs  following  purification.  Protein
purification  was  performed  using  Ni2+-affinity  column
chromatography (see Methods). Lane 1 – molecular weight marker;
Lane 2 – WT αA; Lane 3 – αA NTD; Lane 4 – αA CD; Lane 5 – WT
αB; Lane 6 – αB NTD; Lane 7 – αB CD; and Lane 8 – αB CTE. The
protein band in each preparation showed immunoreactivity to anti-
His tag monoclonal antibody (Results not shown).
In  contrast,  the  αA  NTD  construct  showed  a  marked
difference in secondary structure with 80.5% α-helix, 7.9%
β-sheet, 3.2% β-turn, and 8.4% random coil, suggesting that
the NH2-terminal domain of αA-crystallin by itself assumes a
more helical structure (Figure 3A and Table 3). The αA CD
construct varied slightly from WT αA with 37.9% α-helix,
42.7%  β-sheet,  10.7%  β-turn,  and  9.6%  random  coil,
suggesting that αA CD alone becomes slightly more helical
and retains a secondary structure relatively similar to WT
(Figure 3A and Table 3). Based on SELCON3 analysis, WT
αB exhibited 19.3% α-helix, 48.7% β-sheet, 12.4% β-turn, and
19.6% random coil. However, αB NTD differed in secondary
structural content with 29.9% α-helix, 41.3% β-sheet, 9.1%
β-turn,  and  19.4%  random  coil.  The  increase  in  α-helical
content and slight decrease in β-sheet of αB NTD produced a
readily  visible  difference  in  spectra  compared  to  WT  αB
(Figure 3B). Like αA CD, αB CD also exhibited only a slight
difference in its CD spectra relative to WT αB (Figure 3B), as
the latter showed 20.6% α-helix, 48.1% β-sheet, 14.3% β-turn,
and 18.7% random coil (Table 3). Among the αB-crystallin
constructs, αB CTE showed the most marked difference in
secondary  structure  compared  to  WT,  with  5.9%  α-helix,
66.6% β-sheet, 4.3% β-turn, and 23.5% random coil. αB CTE
also  exhibited  more  random  coil  structure  than  all  other
constructs (Table 3). This noticeable decrease in α-helical
content and increase in β-sheet suggest that, by itself, the
COOH-terminal extension of αB-crystallin has more β-sheet
structure.  Taken  together,  the  results  suggested  that,
individually,  the  domains  flanking  the  α-crystallin  core
domain display greater alterations in secondary structure than
the  core  domains  when  compared  to  their  respective  WT
proteins.  The  most  notable  changes  were  that  the  NH2-
terminal domain construct of αA-crystallin showed greater α-
helical  content  compared  to  WT  αA,  while  the  COOH-
terminal  extension  of  αB-crystallin  showed  a  substantial
decrease in α-helical content and increase in β-sheet content
relative to WT αB.
Surface  hydrophobicity—Changes  to  the  secondary
structure  of  a  protein  likely  affect  its  tertiary  structural
conformation as well. Previous studies have implicated the
TABLE 2. PRESENCE OF WT aA, WT aB, AND THE NH2-TERMINAL, CORE DOMAIN, AND COOH-TERMINAL EXTENSION CONSTRUCTS IN THE
SOLUBLE FRACTION AND/OR INCLUSION BODIES.
Crystallin species Soluble fraction Inclusion bodies
WT αA + -
αA NTD - +
αA CD + +
αA CTE ND* ND*
WT αB + -
αB NTD - +
αB CD + +
αB CTE + -
           + Indicates presence of protein in given fraction on SDS–PAGE. *ND: not determined.
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of target proteins during chaperone function [7,33,35]. In light
of the altered secondary structures of the individual domains
of  αA-  and  αB-crystallins,  we  investigated  surface
hydrophobicity  binding,  among  WT  proteins  and  their
constructs, by using a hydrophobic fluorescence probe, ANS
Figure 3. Far-UV CD spectra of WT αA, WT αB and their individual
domain constructs. Spectra were recorded using protein preparations
of 0.2 mg/ml, dissolved in 50 mM sodium phosphate buffer (pH 7.8),
and a cell path length of 0.5 mm. The reported spectra are the average
of 5 scans, corrected for the buffer blank, and smoothed. A: WT αA,
NH2-terminal  domain,  and  core  domain  constructs.  B:  WT  αB,
NH2-terminal domain, core domain, and COOH-terminal extension
constructs.
(Figure  4).  ANS  is  a  useful  probe  for  assaying  surface
hydrophobicity  because  it  is  non-fluorescent  in  aqueous
solutions, but fluoresces when bound to hydrophobic surfaces,
so its fluorescence correlates to its binding. On ANS binding,
WT αA exhibited fluorescence with λmax peak at 497 nm, and
similarly, αA CD showed a fluorescence peak at 497 nm with
identical intensity. However, with a peak at 507 nm, αA NTD
exhibited a 10 nm red shift relative to WT αA, and it was
coupled with a decrease in fluorescence intensity (Figure 4A).
The results suggest that, relative to WT αA, the N-terminal
domain construct showed a relatively relaxed structure with a
greater exposure of hydrophobic surfaces but a decrease in
binding  intensity,  while  the  αA  core  domain  retained  its
surface hydrophobicity property. Upon binding to ANS, WT
αB  exhibited  a  fluorescence  peak  with  λmax  at  517  nm.
However, αB NTD, CD, and CTE all showed a blue shift
compared  to  WT  αB,  as  well  as  reduced  fluorescence
intensity,  with  peaks  at  495  nm,  488  nm,  and  510  nm,
respectively (Figure 4B). The differences in λmax peaks of the
αB-crystallin constructs relative to WT αB were as follows: a
22 nm shift in the αB NTD peak, a 29 nm shift in αB CD peak,
and a 7 nm shift in αB CTE peak. Of all the constructs, the
COOH-terminal  extension  construct  showed  a  substantial
decrease in fluorescence intensity, compared to WT αB. The
results  suggest  that,  compared  to  WT,  the  individual  αB-
crystallin  domain  constructs  displayed  relatively  compact
structures  with  both  decreased  exposure  of  hydrophobic
surfaces  and  decreased  binding  intensity.  Taken  together,
shifts in fluorescence peaks and changes in intensity suggest
changes  in  the  microenvironments  surrounding  the
hydrophobic  residues  and  imply  changes  to  the  tertiary
structures of these proteins compared to their WT crystallins.
Determination of molecular mass by dynamic light scattering:
To  determine  whether  the  individual  crystallin  domain
constructs were able to oligomerize, the molecular masses of
WT αA, WT αB and their constructs were determined by
multi-angle  light  scattering  (MALS)  analysis  (Wyatt
Technology,  Santa  Barbara,  CA).  Table  4  shows  the
molecular mass of each protein. Compared to WT αA, which
had a mass of 6.8×105 D, the αA NTD and αA CD constructs
showed a mass of 1.6×104 D and 3.0×104 D, respectively.
Individually, the NH2-terminal domain and core domain of
TABLE 3. SECONDARY STRUCTURAL CONTENT OF WT aA, WT aB AND THEIR INDIVIDUAL DOMAIN CONSTRUCTS. PERCENTAGES WERE DETERMINED BY
ANALYSIS OF THE FAR-UV SPECTRA (FIGURE 3) USING THE SELCON3 ANALYSIS PROGRAM.
Crystallin species α-Helix (±1%) β-Sheet (±1%) β-Turn (±1%) Random coil (±1%)
WT αA 21.6 46.6 13.4 17.6
αA NTD 80.5 7.9 3.2 8.4
αA CD 37.9 42.7 10.7 9.6
WT αB 19.3 48.7 12.4 19.6
αB NTD 29.9 41.3 9.1 19.4
αB CD 20.6 48.1 14.3 18.7
αB CTE 5.9 66.6 4.3 23.5
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2361αA-crystallin form smaller oligomers, though the core domain
forms  slightly  larger  oligomers  than  the  NH2-terminal
domain. Similar to WT αA, WT αB had a mass of 5.8×105 D.
Compared to WT αB, αB NTD displayed a mass of 2.6×103
D, however, both αB CD and αB CTE showed increases in
mass of 8.4×107 D and 1.0×106 D, respectively. Unlike αA,
the NH2-terminal domain of αB forms smaller oligomers,
while the core domain and COOH-terminal extension both
form much larger oligomers compared to WT αB.
Chaperone activity of WT α-crystallins and individual domain
constructs:  To  determine  if  the  individual  α-crystallin
domains retain functionality, the chaperone activity of these
constructs  was  assayed.  Insulin  along  with  other  target
proteins  such  as  alcohol  dehydrogenase,  lysozyme,  and
lactalbumin has provided comparable results in previously
published reports [13,25,29]. Thus, the chaperone activities
of WT αA and WT αB and their individual domain constructs
were determined using insulin (100 μg) as the target protein
in a 1:1 ratio. Light scattering at 360 nm was used to measure
aggregation of the insulin B chain by reduction with DTT in
the presence and absence of chaperone proteins. Chaperone
activity was represented as the percent protection provided by
the  crystallins  (Figure  5).  WT  αA  exhibited  about  90%
protection against DTT-induced insulin aggregation, whereas
both αA NTD and αA CD constructs showed a decrease in
chaperone activity, providing about 65% and 60% protection,
respectively. Similar to WT αA, WT αB exhibited about 95%
protection  against  insulin  aggregation.  However,  both  αB
NTD and αB CD constructs showed decreased chaperone
activity  compared  to  WT.  αB  NTD  showed  the  greatest
protection at about 85%, while αB CD showed about 70%.
αB CTE provided only minimal protection to insulin at about
25%. In general, among the constructs, chaperone activity
decreased  as  follows:  NTD>CD>CTE.  More  specifically,
chaperone  activity  across  all  proteins  decreased  in  the
following order: WT αB> WT αA> αB NTD> αB CD> αA
NTD> αA CD> αB CTE (Figure 5). Taken together, the results
suggested that isolating the individual domains of both αA-
and αB-crystallins, particularly the NH2-terminal domains,
affected the chaperone activity of the proteins, but did not
completely deplete their function.
DISCUSSION
The  purpose  of  the  present  study  was  to  understand  the
biophysical  and  functional  aspects  of  the  NH2-terminal
Figure  4.  Fluorescence  spectra  of  WT  αA,  WT  αB  and  their
individual domain constructs following ANS binding. Fluorescence
spectra were recorded by excitation at 390 nm and emission from
400 to 600 nm, with protein preparations (0.2 mg/ml) mixed with 15
μl of 0.8 mM ANS (dissolved in methanol) and incubated at 37 °C
for 15 min. A: WT αA, NH2-terminal domain, and core domain
constructs.  B:  WT  αB,  NH2-terminal  domain,  core  domain,  and
COOH-terminal  extension  constructs.  Dotted  lines  indicate  the
maximum peak wavelength (λmax) of the respective WT α-crystallins,
used to determine whether a blue or red shift in wavelength occurred.
TABLE 4. MOLAR MASS DETERMINATION OF WT aA, WT aB AND THEIR INDIVIDUAL DOMAIN CONSTRUCTS USING THE
DYNAMIC LIGHT SCATTERING METHOD (MALS).
Crystallin species Molecular mass (Da)
WT αA 6.8×10
5
αA NTD 1.6×10
4
αA CD 3.0×10
4
WT αB 5.8×10
5
αB NTD 2.6×10
3
αB CD 8.4×10
7
αB CTE 1.0×10
6
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2362domain, core domain, and COOH-terminal extension of both
αA-  and  αB-crystallins,  with  the  intent  to  find  molecules
(peptides) of αA and αB which can assist in the correct folding
of  other  proteins  or  in  sequestering  misfolded/improperly
folded proteins, and also eventually act as a targeting drug.
The present study was the first step toward our long-term
objective. To accomplish this, individual constructs of NH2-
terminal domain, core domain, and COOH-terminal extension
of both αA- and αB-crystallins were generated and used for
comparative structural and functional analyses to ascertain
which region is most pertinent to chaperone function. Two
constructs of αA-crystallin (i.e., αA NH2-terminal domain
[αA NTD, residues 1–63] and core domain [αA CD, residues
64–142]) and three constructs of αB-crystallin (i.e., αB NH2-
terminal domain [αB NTD residues 1–66], core domain [αB
CD, residues 67–146], and COOH-terminal extension [αB
CTE, residues 147–175]) were generated. One construct, αA
COOH-terminal extension [αA CTE, residues 143–173] could
not be successfully generated even after several attempts and
using variable conditions. This could be due to one of the
templates being technically difficult to amplify, with high GC
content or other structures that cause DNA polymerase to stop
or pause. Our failure could also be due to other reasons, which
are presently unknown to us.
The reason for selectively using the three recombinant
regions (i.e., NH2-terminal domain, core domain, and COOH-
terminal  extension)  of  αA-  and  αB-crystallins  for  the
comparative structural and functional studies was because
several past reports have described effects of either partial
deletion or mutation in the three regions, but never examined
the properties of each individual region relative to their WT
proteins. Further, based on preliminary experimental evidence
in the literature, a persistent belief exists that the chaperone
proteins/peptides  could  be  the  key  to  treating  a  range  of
diseases  related  to  protein  misfolding,  such  as  cataract,
Alzheimer and Parkinson. Our experimental approach was
similar to several past reports that considered the three regions
of the two crystallins as modules to determine their affect on
crystallin  structural  stability  and  function.  Some  such
Figure 5. Chaperone activity comparison of WT αA and αB and their
individual domain constructs. The chaperone activity, calculated as
% protection, was assayed by measuring DTT-induced insulin (100
μg) aggregation in the presence of chaperone/insulin ration (1:1) at
25 °C. Error bars=Percent Error (+/− 1%).
examples  are  as  listed:  (1)  Merck  et  al.  [36]  studied
recombinant  NH2-terminal  domain  and  COOH-terminal
domain of αA-crystallin, and concluded that the interactions
leading to aggregation of αA-crystallin subunits are mainly
located in the NH2-terminal half of the chain. (2) Merck et al.
[37]  also  compared  the  COOH-terminal  domain  and  tail
region of αA crystallin from rat, bovine αB crystallin and
mouse HSP25, to show that the COOH-terminal domain of
αA formed dimers and tetramers, but corresponding regions
of αB and HSP25 formed larger aggregates and the COOH-
terminal  domain  lacked  heat  protection  activity.  (3)  The
swapping of the COOH-terminal extension of αA-crystallin
to  the  COOH-terminal  extension  of  αB  led  to  enhanced
chaperone  activity  of  the  latter  [29],  suggesting  that  in
addition to the solubilizer property of this region, it also plays
a crucial role in structural stability and chaperone activity. (4)
Kokke  et  al.  [38]  used  Hsp12.2  from  roundworm
Caenorhabditis elegans to study the role of the α-crystallin
domain. Although Hsp12.2 forms oligomers like other sHSPs,
it lacks chaperone activity. In spite of addition of the NH2-
terminal domain and COOH-terminal extension of human
αB-crystallin  to  the  α-crystallin  domain  of  Hsp12.2,  the
chaperone activity was not restored. The results suggested that
proper synergism between different regions is necessary for
chaperone activity. (5) To determine the role of NH2- and
COOH-terminal  sequences  in  assembly  and  function  of
sHSPs, Ghosh et al. [39] used two deletion mutants, ∆41–58
(lacking residues 41–58 of the NH2-terminal domain) and
∆155–165 (lacking residue no. 155–165). These two regions
were identified as interacting regions in formation of αB-
crystallin  oligomers  [40].  Oligomers  of  the  two  deletion
mutants were larger and more polydisperse relative to WT
αB. The ∆41–58 mutant showed the same level of chaperone
activity as WT αB whereas the ∆155–165 mutant lost its
chaperone activity and solubility. (6) Smulders et al. [41]
reported that on insertion of either charged residues (Lys, Arg
and  Asp)  or  a  hydrophobic  residue  (Trp)  in  the  COOH-
terminal  extension  of  αA,  only  the  insertion  of  the
hydrophobic  residue  seriously  disturbed  the  structure  and
function of the crystallin. (7) Peptides as minichaperones of
both  αA-  (residue  no.  78–88  [in  the  α-crystallin  domain
region])  and  αB-  (residue  no.  73–92  [in  the  α-crystallin
domain region]) crystallins have been extensively studied for
their structural and functional properties [12,13]. Because
these are functional elements (peptides of both αA and αB-
crystallins), they suggest a lesser requirement of both NH2-
terminal  domain  and  COOH-terminal  extension  of  the
crystallins in their chaperone activity.
Each of the constructs in our study was confirmed by
DNA sequencing. Similarly, the specific protein products of
the  constructs  were  confirmed  by  their  expected  Mr’s
following SDS–PAGE analysis, and by immunoreactivity to
an anti-His-tag antibody during western blot analysis. Each of
the His-tagged proteins was purified by one step Ni2+-affinity
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2363column chromatography, and SDS–PAGE analysis showed
their recovery in highly purified forms (Figure 2).
The following were the major findings of the study: (1)
In contrast to the high content of 46.6% β-sheet and only
21.6% α-helix in WT αA, αA NTD showed high α-helix
(80.5%)  and  substantially  low  (7.9%)  β-sheet  content.
Similarly, the αA CD construct showed 37.9% α-helix and
42.7% β-sheet content, suggesting that both the NH2-terminal
domain and core domain alone of αA-crystallin assume a more
helical structure than WT αA (Figure 3A and Table 3). (2)
Relative to 19.3% α-helix and 48.7% β-sheet content of WT
αB, αB NTD also showed a higher α-helical content of 29.9%,
and  a  lower  β-sheet  content  of  41.3%.  However,  αB  CD
showed 20.6% α-helix and 48.1% β-sheet, which was similar
to WT αB-crystallin. In contrast, αB CTE showed only 5.9%
α-helix  and  66.6%  β-sheet,  which  was  the  most  marked
difference in secondary structure compared to WT αB. (3) On
determination of hydrophobicity by ANS-binding, WT αA
and αA CD exhibited λmax fluorescence peaks at 497 nm with
identical intensity, whereas αA NTD exhibited a 10 nm red
shift with a λmax peak at 507 nm, suggesting that the secondary
structure  was  relatively  relaxed  with  greater  exposed
hydrophobic surfaces. On a similar ANS binding, WT αB
showed λmax at 517 nm, whereas αB NTD, αB CD, and αB
CTE showed blue shifts compared to WT with λmax peaks at
495 nm, 488 nm, and 510 nm, respectively. Therefore, relative
to WT αB, the differences in λmax peaks of the αB-crystallin
constructs were as follows: a 22 nm shift in the αB NTD peak,
a 29 nm shift in the αB CD peak, and a 7 nm shift in the αB
CTE peak. Together, the results suggest that compared to WT,
the  individual  αB  constructs  displayed  relatively  compact
structures with a decrease in both exposure of hydrophobic
surfaces and binding intensity. (4) The MALS results showed
that relative to a Mr of 6.8×105 Da of WT αA oligomers, its
constructs also oligomerized but exhibited lower molecular
mass  (i.e.,  αA  NTD  and  αA  CD  Mr  of  1.6×104  Da  and
3.0×104 Da, respectively). Similarly, relative to the Mr of
5.8×105  Da  of  WT  αB,  the  αB  NTD  construct  showed  a
substantially lower Mr of 2.6×103 Da, while the other two
constructs  showed  higher  Mr  (i.e.,  αB  CD  and  αB  CTE
displayed  8.4×107  Da  and  1.0×106  Da,  respectively).
Therefore, relative to the NH2-terminal domain of αB, both
the core domain and COOH-terminal extension of αB formed
much  larger  oligomers,  which  were  even  bigger  than  the
oligomers of WT αB. (5) WT αA and WT αB exhibited almost
the same levels of about 90% protection against DTT-induced
insulin aggregation. However, both NH2-terminal and core
domain  constructs  of  αA  also  showed  65%  and  60%
protection, respectively. Similarly, αB NTD, αB CD and αB
CTE  exhibited  protection  at  about  85%,  70%,  and  25%,
respectively.  Together,  the  results  show  a  slightly  greater
chaperone activity of the NH2-terminal domain of αB relative
to NH2-terminal domain of αA, but similar levels of activity
of core domain of the two crystallins. The COOH-terminal
extension construct of αB exhibited substantially low (25%)
chaperone activity relative to all other regions of both αA and
αB-crystallins. We anticipate a similar low level of chaperone
activity of αA CTE as has been reported previously [37].
The above differences in the structural and functional
properties in the three regions of αA and αB were seen in spite
of their origin via gene duplication and having ~57% sequence
homology [42]. Some other examples showing differences in
the  two  crystallins  include:  recombinant  αA-  and  αB-
crystallins differ in their secondary and tertiary structures, and
relative  to  αA,  αB  showed  a  greater  hydrophobicity  and
fourfold more chaperone activity [43]. Other reports showed
that  αA-crystallin  was  more  stable  to  gamma  irradiation
relative to αB [44], and although αA- and αB-crystallins can
each form oligomers independently, together or with other
crystallins, their interactions with each other were threefold
greater than their interactions with βB2- and γC-crystallins
[45].  Both  crystallins  also  exhibit  varied  expression  in
different diseases. While αA is lens specific, αB-crystallin is
widely  expressed  in  other  tissues,  most  prominently  in
astrocytes [46] and muscles [47]. αB has also been detected
in the brain and associated with neurologic diseases such as
Alzheimer [48], Parkinson [49], Creutzfeldt-Jakob disease
[50], Alexander disease [51] and diffuse Lewy body disease
[52].
As  stated  above,  like  other  sHSPs,  α-crystallin  also
contains a highly conserved sequence of 80–100 residues
called the α-crystallin domain [2,29]. Based on similarities
with the structures of other HSPs, it is believed that the NH2-
terminal  regions  of  both  αA-  and  αB-crystallins  form
independently folded domains, whereas the COOH-terminal
region is flexible and unstructured [2,29]. Our CD spectra
results  also  suggest  that  the  NH2-terminal  domain  of  αA
indeed formed an independently folded domain with high
content of α-helix (80.5%) and low β-sheet (7.9%) compared
to 46.6% β-sheet and 21.6% α-helix in WT αA. Similarly, αB
NTD with 29.9% α-helix and 41.3% β-sheet also exhibited
distinct secondary structure compared to WT αB with 19.3%
α-helix, and 48.7% β-sheet. Because of the absence of data
regarding the secondary structure of αA CTE, we could only
compare the secondary structural data of αB CTE (5.9% α-
helix, 66.6% β-sheet) with WT αB (19.3% α-helix, 48.7% β-
sheet). The results show that αB CTE assumes a greater β-
sheet structure relative to WT αB. αA NTD showed drastic
differences  in  secondary  structure  because  of  significant
increase in α-helical content and concurrent decrease in β-
sheet content. The results of altered secondary structures of
NH2-terminal domains of αA and αB compared to their WT
proteins were also supported by their ANS binding results and
molecular mass determined by the MALS method. Relative
to WT αA (λmax at 497 nm), αA NTD exhibited a λmax peak at
507 nm with a 10 nm red shift whereas, compared to WT αB
(λmax at 517 nm), αB NTD showed λmax of 495 nm with a 22
nm blue shift. Therefore, both αA NTD and αB NTD exhibited
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2364altered hydrophobicity relative to their WT proteins, but the
former acquired a relatively relaxed structure and the latter a
compact structure. Additionally, relative to molecular mass of
6.8×105 Da of WT αA and 5.8×105 Da of WT αB, both αA
NTD  and  αB  NTD  exhibited  oligomers  with  mass  of
1.6×104  Da  and  2.6×103  Da,  respectively.  The  lower
molecular mass of αB NTD compared to αA NTD supports
their  blue  and  red  spectral  shifts  during  ANS  binding,
respectively. On ANS binding, both WT αA and αA CD
exhibited λmax fluorescence peaks at 497 nm with identical
intensity, however, the molecular mass of αA CD (3.0×104 D)
was significantly lower than that of WT αA (6.8×105 D). Both
αB CD and αB CTE showed a blue shift with λmax of 488 and
510 nm, respectively. These results clearly showed changes
in the microenvironment of hydrophobic patches of αB CD
and αB CTE. However, in spite of compact structure, both
αB CD and αB CTE displayed higher molecular mass of
8.4×107 D and 1.0×106 D, respectively, compared to WT αB.
Together, the results show a greater tendency of αB CD and
αB CTE to form oligomers of bigger sizes compared to those
αA NTD, αB NTD and αACD. Further, interestingly, each
region of both αA and αB could form oligomers in the same
manner as full-length α-crystallins.
The present study showed that all three regions of both
αA-  and  αB-crystallins  are  involved  in  varied  levels  of
chaperone activity. While both WT αA and WT αB exhibited
almost  the  same  levels  (~90%)  protection  against  DTT-
induced insulin aggregation, the higher level of chaperone
activity  of  the  NH2-terminal  domains  of  both  crystallins
relative to their core domains and COOH-terminal extension
suggest that it is most relevant among the three regions for the
chaperone  activity.  This  is  supported  by  previous  reports
showing that, primarily, the residues within the NH2-terminal
domain or near it are involved in chaperone substrate binding,
i.e., residues 70–88 of αA-crystallin [12], as well as residues
73–92 of αB-crystallin [13]. Similarly, residues 54–61 of αB-
crystallin  are  essential  for  its  chaperone  activity  although
unessential for target protein binding [14].
Reports  have  suggested  that,  as  in  other  sHSPs,  the
NH2-terminal  domain  of  αA-crystallin  is  important  for
chaperone  activity,  self-assembly  into  oligomers,  and
structural stability. Our previous report has shown that the
deletion of the NH2-terminal domain of αA resulted in altered
structure  with  properties  such  as  increased  hydrophobic
patches, β-sheet content, and subunit exchange rate with WT-
αB, but reduced oligomer mass and chaperone activity [22].
Residues 12–21 and 70–88 in the NH2-terminal domain of
αA were identified as substrate binding sites [12]. Similarly,
two bis-ANS binding sites at residues 50–54 and 79–99 were
also identified [53]. Deletion of 1–63 amino acid residues in
bovine  α-crystallin  resulted  in  the  formation  of  only  a
tetrameric  species  [54],  suggesting  severely  diminished
oligomerization property. This is consistent with the peptide
scan results, which showed that residues 42–57 and 60–71 of
αA play a role in oligomerization and subunit interactions
[55].
Our study showed little chaperone activity in the COOH-
terminal extension of αB-crystallin, which is in parallel with
previous studies which showed that on the removal of NH2-
terminal  residues  (partial  or  1–56  residues  of  the  NH2-
terminus) and COOH-terminal extension residues (partial or
32–34  residues  of  the  COOH-terminus)  of  αA-  and  αB-
crystallins, the proteins showed improper folding [2], reduced
chaperone activity [22], and formation of trimers or tetramers
[53-55].
In summary, we have taken an alternative approach in this
study than the previously published reports that examined
whether mutation or deletion of amino acids in any of the three
regions of both αA- and αB-crystallins have effects on their
structural  and  functional  properties.  The  most  intriguing
finding  of  the  present  study  was  that  although  the  three
different regions (i.e., NH2-terminal domain, core domain,
and  COOH-terminal  extension)  of  both  αA-  and  αB-
crystallins  have  different  secondary  structures,  surface
hydrophobicity  and  oligomerization  properties,  they
individually retain variable levels of chaperone activity.
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